HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.0050
Year range
$0.0050 - $0.035
Market cap
285.35K CAD
Avg Volume
41.60K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.00K | -97.46% |
Net income | -11.24K | 93.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 11.55K | 109.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.68K | -40.38% |
Total assets | 6.68K | -99.30% |
Total liabilities | 903.22K | -3.03% |
Total equity | -896.54K | — |
Shares outstanding | 57.07M | — |
Price to book | -0.25 | — |
Return on assets | -77.13% | — |
Return on capital | 1.24% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -11.24K | 93.67% |
Cash from operations | -12.55K | 50.35% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -12.55K | -22.16% |
Free cash flow | -5.43K | 65.83% |
About
Headquarters
Website
